The FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) is responsible for regulating drug companies' promotional materials. Regulatory and communications experts will provide tips on how to avoid receiving a DDMAC Warning Letter that can cause companies major headaches, particularly for smaller biotechs.



Objectives:

Educate industry management and leaders on the importance of DDMAC.

Educate the audience on when and where DDMAC plays a role in product and corporate communications, including do's and don'ts for companies.

Provide a thought-provoking discussion on the role of DDMAC in the biotechnology industry.